Abstract:Epigenetic changes in gene expression due to extensive CpG island methylation is now accepted as the main cause of inactivation of the p16 gene. More recently, it has been suggested that the human ras association domain family (RASSF) 1 gene, cloned from the lung tumor-suppressor locus 3p21.3, also may be inactivated by methylation. It consists of two major alternative transcripts, RASSF1A and RASSF1C. Epigenetic inactivation of isoform A was observed in several carcinomas and tumor cell lines. In this study, promoter hypermethylation of RASSF1A and p16 was investigated in 83 hepatocellular carcinoma (HCC) tissue samples from Taiwan and in two HCC cell lines (Hep3B and HepG2). High frequencies (85% and 47%, respectively) of methylation of the CpG island promoters of RASSF1A and p16 were found in the HCC tissues. The methylation of RASSF1A also was detected in Hep3B cells but not in HepG2 cells; p16 was not methylated in either cell line. Methylation status was determined in 12 normal control liver tissues and 10 adjacent nontumor tissues. No methylation was found in normal liver control tissues for both RASSF1A and p16; methylation was detected in one of 10 and seven of 10 adjacent nontumor tissue sampless for p16 and RASSF1A, respectively, in subjects with positive tumors. These data indicate that aberrant methylation of the CpG island promoters of both genes is a frequent occurrence in hepatocarcinogenesis. The high frequency of RASSF1A methylation in adjacent tissues suggests that this may be an early event. The relationship between methylation status and clinical parameters and tumor markers, including DNA damage resulting from aflatoxin B(1) (AFB(1)), an environmental carcinogen, and p53 status, also was analyzed. A statistically significant association was found between RASSF1A methylation status and the level of AFB(1)-DNA adducts in tumor tissues. No association was found between methylation status and p53 status. These results suggest the hypothesis that exposure to environmental carcinogens may be involved in altered methylation of genes involved in cancer development.

Promoter Methylation Status and Protein Expression of P14arf Gene in Hepatocellular Carcinoma

Association of Low P16ink4a and P15ink4b Mrnas Expression with Their Cpg Islands Methylation with Human Hepatocellular Carcinogenesis

Hypermethylation-mediated Transcriptional Silencing of Lncrna-Scarf1 Promotes Progression and Metastasis of Hepatocellular Carcinoma

The expression and promoter methylation of SLIT2 gene in human primary hepatocellular carcinomas

Aberrant Methylation Status of SPG20 Promoter in Hepatocellular Carcinoma: A Potential Tumor Metastasis Biomarker.

Clinical Significance of Methylation of E-cadherin and P14arf Gene Promoters in Skin Squamous Cell Carcinoma Tissues.

Hypomethylation Status of Mir-657 Promoter Region As Biomarker for Diagnosis of Hepatocellular Carcinoma: a Retrospective Study

The Association Between Methylation Patterns of DNAH17 and Clinicopathological Factors in Hepatocellular Carcinoma

Promoter Hypermethylation of P16 Gene and DAPK Gene in Sera from Hepatocellular Carcinoma (HCC) Patients

Expression of Pokemon and P14~(ARF) Protein in Hepatocellular Carcinoma and Their Clinical Significance

Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma

Expression and relationship of STAT3 and p14~(ARF) protein in hepatocellular carcinoma

Analysis of Promoter Hypermethylation of P16 Gene,afp and CEA in Sera from Primary Liver Cancer Patients

Promoter Hypomethylation is Responsible for Upregulated Expression of HAI-1 in Hepatocellular Carcinoma.

High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma

P16 Methylation Was Associated with the Development, Age, Hepatic Viruses Infection of Hepatocellular Carcinoma, and P16 Expression Had a Poor Survival

CSF1R methylation is a key regulatory mechanism of tumor-associated macrophages in hepatocellular carcinoma.

Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients

Relationship between promoter methylation status and protein expression of the wwox gene in hepatocellular carcinoma

Prognostic Significance of Preoperative Serum Alpha- Fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.

Hypermethylation of GNA14 and Its Tumor-Suppressive Role in Hepatitis B Virus-Related Hepatocellular Carcinoma.